Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Deep Green is a biotechnology company specializing in the production of high-quality, full-spectrum cannabis oil extracts for medical and therapeutic use. The company utilizes proprietary extraction and refinement processes to preserve the complete profile of cannabinoids and terpenes found in the plant, aiming to maximize the therapeutic potential known as the entourage effect. Their products are primarily targeted toward patients managing chronic conditions such as pain, epilepsy, and inflammation. Deep Green focuses on rigorous testing and standardization to ensure safety and efficacy for medical-grade applications. By bridging the gap between traditional herbal medicine and modern pharmaceutical standards, the company provides consistent formulations for the healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Deep Green.